Expanding our Presence in Acute Care

• Continuous Renal Replacement Therapy (CRRT) for patients suffering from acute renal failure

• Highly profitable market growing 15%

• Leverages Baxter’s hospital relationships

• Complete and differentiated portfolio including:

  • Accura Instrument: New standard in ease-of-use with significant therapy advantages
  • Accusol Solution: Innovative, dual chambered, ready-to-mix bicarbonate solution
  • Hemofilters: Biocompatible, polysulfone filters

• Launches in U.S., Europe and Asia targetedfor 2002

Previous slide

Next slide

Back to first slide

View graphic version